Pillar Guide · Updated August 28, 2026

How Much Do GLP-1 Medications Cost in 2026? The Complete Breakdown

Current brand list prices are roughly $1,028 to $1,349 per month, while eligible patients may pay less through insurance or manufacturer programs. Advertised compounded-program prices can be lower, but compounded GLP-1 drugs are not FDA-approved and are not generic versions of the brands. ClearMetabolic tracks 94 providers; this guide separates list price, savings offers, Medicare options, and advertised telehealth pricing.

Brand-Name GLP-1 Prices (List Price)

These are the manufacturer list prices (also called WAC or wholesale acquisition cost). This is what you pay without any insurance or discount programs.

Why prices vary between diabetes and weight-management products: Ozempic and Wegovy both contain semaglutide; Mounjaro and Zepbound both contain tirzepatide. They are distinct FDA-approved products with different labels, presentations, dosing, and indications. Coverage depends on the exact product, indication, and plan.

Important context: List price is not a prediction of what a patient will pay. Insurance, deductible status, pharmacy pricing, manufacturer terms, and program eligibility determine the actual amount.

Compounded GLP-1 Prices

Some providers advertise patient-specific compounded semaglutide or tirzepatide made under federal and state compounding rules. These products are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing. FDA also warns that compounded products should not be marketed as generics or as having the “same active ingredient” as an approved drug.

Compounded Semaglutide

Compounded Tirzepatide

The regulatory caveat: The FDA resolved the tirzepatide shortage in October 2024 and the semaglutide shortage in February 2025. In 2026, FDA announced enforcement priorities involving mass-marketed non-FDA-approved GLP-1 products. Patient-specific compounding may remain lawful only when all applicable conditions are met. See our compounded vs brand-name guide for the full regulatory picture.

Cash-Pay Comparison: 15 Providers and Direct Programs

Here are advertised starting prices recorded in our provider database. They can exclude membership fees, dose increases, labs, or shipping and should be verified directly before purchase. ClearMetabolic tracks 94 providers.

Prices change frequently. Visit our full provider comparison for the most current rates across all 94 providers.

Insurance Coverage

There is no reliable national percentage showing how many commercial plans cover GLP-1 medications for weight management. Employer groups can include or exclude obesity-drug benefits even when they use the same insurer, so verify the exact formulary and benefit document.

UnitedHealthcare, Aetna, Cigna, Blue Cross and Blue Shield organizations, Kaiser, and Humana all administer plans with different formularies and employer exclusions. Treat the member portal, formulary, and plan document as authoritative for the exact product and indication.

Prior authorization (PA) is common for weight-management GLP-1s. Criteria and processing times vary by plan and may include the labeled BMI criteria, comorbidities, prior treatment, or participation requirements.

Step therapy applies in some plans. If it appears in the criteria, ask which alternatives and durations count and whether a contraindication or prior trial satisfies the rule.

For the complete insurance playbook, including how to get prior auth approved and how to appeal denials, see our insurance coverage guide.

Manufacturer Savings Cards and Patient Assistance

Both Novo Nordisk and Eli Lilly offer programs to reduce out-of-pocket costs.

Eli Lilly Savings Programs (Mounjaro/Zepbound)

• Zepbound Savings Card: Eligible commercially insured patients may pay as little as $25/month. Restrictions apply.
• LillyDirect Self-Pay Vials: Zepbound is $299 for 2.5 mg, $399 for 5 mg, and as low as $449 for 7.5-15 mg through the Journey program when refill-timing and other requirements are met.
• Patient assistance: Check Lilly Cares for the current covered-product list and product-specific eligibility rather than assuming Mounjaro or Zepbound is included.

Novo Nordisk Savings Programs (Ozempic/Wegovy)

• NovoCare insured offer: Eligible commercially insured patients may pay as little as $25/month, subject to a $100 monthly maximum benefit and current terms.
• NovoCare self-pay: Wegovy tablets start at $149 for the 1.5mg and 4mg doses under the current time-limited offer. New patients can receive the first two Wegovy 0.25mg and 0.5mg injection fills for $199 each through December 31, 2026; standard injection self-pay is $349 and Wegovy HD is $399.
• Novo Nordisk PAP: Product availability and income rules vary. NovoCare says some medicines left the program in 2026 and lists a 200% federal-poverty-level ceiling for uninsured Ozempic patients versus 400% for other included medicines.

Key distinction: Copay-card benefits cannot be processed with government insurance. Some manufacturers separately let government-insured patients buy at a self-pay price outside their insurance; those payments do not count toward the plan deductible or out-of-pocket limit. Medicare beneficiaries should also check the Medicare coverage guide.

For the full breakdown of copay cards and patient assistance, see our copay cards and patient assistance guide.

Medicare Coverage (New in 2026)

Medicare coverage now has two separate paths:

• Normal Part D coverage: A plan may cover a GLP-1 for a coverable FDA-approved indication, such as type 2 diabetes, Wegovy’s cardiovascular indication, or Zepbound’s obstructive-sleep-apnea indication. Formulary rules and prior authorization still apply.
• Medicare GLP-1 Bridge: Since July 1, 2026, eligible Part D beneficiaries can obtain Foundayo, all Wegovy formulations, or Zepbound KwikPen for weight management for $50 per month. The nationwide bridge requires prior authorization and runs through December 31, 2027.

The bridge is separate from ordinary Part D formulary coverage. Check eligibility through Medicare rather than assuming that every GLP-1 or every beneficiary qualifies.

Our Medicare GLP-1 coverage guide covers every option in detail.

FSA/HSA Eligibility

GLP-1 medications are FSA and HSA eligible when prescribed for a diagnosed medical condition. This includes:

• The medication itself (brand-name or compounded)
• Telehealth consultation fees
• Lab work
• Shipping costs when the administrator treats them as part of the qualified expense; request an itemized receipt
• Injection supplies

Using an FSA or HSA can reduce taxes on qualified expenses, but the amount depends on contribution method, marginal rates, state law, and eligibility. As a simple federal-income-tax illustration, $2,400 of qualified spending multiplied by a 24% marginal rate is $576; that is not a guaranteed tax result and does not automatically include FICA savings.

FSA salary-reduction limit (2026): $3,400 (plan design controls availability and carryover) HSA contribution limit (2026): $4,400 self-only, $8,750 family, plus a $1,000 catch-up for eligible people age 55 or older

For the full breakdown of what qualifies, how to submit claims, and which providers accept FSA/HSA directly, see our FSA/HSA guide.

The Compounded vs. Brand-Name Debate

This is the biggest decision most GLP-1 patients face. Here is an honest comparison:

My take: If an FDA-approved product is available, medically appropriate, and affordable, it has clear evidence and regulatory advantages: the marketed product was reviewed by FDA and its manufacturing controls and labeling are product-specific.

If brand-name treatment remains unaffordable, ask the prescriber about approved alternatives, manufacturer self-pay programs, and whether a patient-specific compounded product is medically necessary. “503B” describes an outsourcing-facility category; it does not mean the finished drug is FDA-approved.

For the full analysis, see our compounded vs brand-name guide.

How to Find the Cheapest Option for Your Situation

The cheapest GLP-1 path depends on your insurance status, income, and which medication you prefer. Here is a decision tree:

1. Do you have commercial insurance?

• Check if your plan covers Wegovy or Zepbound (call the number on your card)
• If yes: get prior authorization, then apply for manufacturer savings card ($25/month possible)
• If no: move to step 2

2. Are you on Medicare?

• If you have type 2 diabetes: Ozempic or Mounjaro may be covered under Part D
• If seeking weight-management treatment: check eligibility for the $50/month Medicare GLP-1 Bridge
• See our Medicare guide

3. Do you qualify for patient assistance?

• Check the manufacturer’s current product list plus income and insurance requirements
• Do not assume every GLP-1 is included in a foundation program

4. Cash-pay, no assistance?

• Compare current approved-product self-pay offers first
• If a prescriber identifies a patient-specific need for compounding, verify the pharmacy or outsourcing facility, all-in price, and exact formulation
• Lilly’s current Zepbound offer starts at $299/month under its terms
• See our cheapest GLP-1 guide for the full comparison

5. Already on a GLP-1 and want to reduce cost?

• Ask about an FDA-approved product with better formulary coverage or a manufacturer self-pay offer
• Use FSA/HSA for pre-tax savings
• Ask the prescriber whether the current product and prescribed dose remain appropriate; do not reduce a dose solely to save money

The True 12-Month Cost

The monthly medication price may be only part of the story. Consultations, labs, dose changes, shipping, and supplies can change the annual total. The examples below are planning illustrations, not quotes.

For the full 12-month cost breakdown with every hidden expense, see our true cost of GLP-1 guide.

FAQ

What is the cheapest way to get GLP-1 medications in 2026?

The lowest advertised price depends on insurance, diagnosis, dose, and eligibility. Some commercially insured patients may pay $25 with a manufacturer card; eligible Medicare beneficiaries may pay $50 through the GLP-1 Bridge; Zepbound self-pay starts at $299. Compounded programs may advertise lower prices, but the drugs are not FDA-approved and are not generic equivalents.

Does insurance cover GLP-1 medications for weight loss?

Coverage varies by the exact employer or individual plan; there is no dependable national percentage. Many plans use prior authorization. Check the formulary and obesity-drug benefit for your specific plan, then see our insurance coverage guide.

How much does Ozempic cost without insurance?

Ozempic’s current list price is $1,027.51 per 28-day supply. NovoCare currently lists eligible self-pay prices of $349 for the 0.25mg, 0.5mg, or 1mg pen and $499 for the 2mg pen, subject to terms. Commercially insured patients have a separate copay offer.

Are compounded GLP-1 medications safe?

Compounded GLP-1 medications are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing. FDA says they should be used only when an approved drug cannot meet an individual patient’s medical need. A licensed prescriber should assess whether compounding is appropriate.

Related

Cost Guides:

• Cheapest GLP-1 Online · Without Insurance · Insurance Coverage
• Copay Cards and Patient Assistance · FSA/HSA Guide · True Cost: 12 Months
• Medicare Coverage · Compounded vs Brand-Name

Other Guides:

• Side Effects Complete Guide · Side Effects Month by Month · Exercise and Muscle
• Mounjaro Dosage Guide · DEXA Scan Results

Medications: Mounjaro · Wegovy · Ozempic · Zepbound

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Tools: GLP-1 Cost Estimator · Body Composition Calculator

Compare: All Providers · Best GLP-1 Programs · All Guides